Skip to main content
MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
10.88
-0.26 (-2.33%)
At close: Apr 28, 2026, 4:00 PM EDT
11.10
+0.22 (2.02%)
Pre-market: Apr 29, 2026, 4:00 AM EDT

MiNK Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
23
Market Cap
54.03M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cue Biopharma 27.47M
Metagenomi Therapeutics 25.21M
MindWalk Holdings 20.70M
Radiopharm Theranostics 10.86M
iBio, Inc. 300.00K
Entera Bio 42.00K
Revenue Rankings

INKT News

More News